NASDAQ NMS - GLOBAL MARKET · GRAL
+6.30% · +$8.35 · Vol 774.1K
Market closed · last close 4:00 PM ET · price as of 19:45:55 ET
Grail Inc

Grail Inc

Biotechnology
$140.96
Card
Relationship Map

Follow $GRAL

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $GRAL by email

Veridion Score

BETAMEDIUM CONF · 6 of 6 factors measuredMethodology
GRAL
Grail Inc
Fri Oct 9 · last completed session · Markets closed · resumes Mon 9:30 ET
Upper range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

83/ 100
Veridion Score
Upper range · MEDIUM confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 6 of 6 factors measured · Fri Oct 9 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is GRAL moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading GRAL catalysts
About Grail Inc
SERVICES-MEDICAL LABORATORIES
Listed since
2024
Employees
910
Country
US

GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$133.50
Day high
$142.57
Day low
$133.31
Previous close
$132.61
52W high
$154.08
-8.51% from high
52W low
$43.03
88% of range
Market cap
$5.9B
EPS
$-9.7458
Beta
-0.41
Shares out
44.7M
Volume
774.1K
0.60× rel vol
Avg volume
1.3M
VWAP
$140.09
Price history computed in-house
1W
-1.60%
1M
+81.74%
3M
+95.78%
1Y
+113.16%
YTD
+64.69%
SMA 50 $91.36 · above
SMA 200 $74.87 · above
52W position 88%

GRAL overview

Veridion Score
83
Registered · 2026-10-09
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around GRAL.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading GRAL Form 4 filings
Public disclosures

Congress activity in GRAL

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified filings found.

Federal contracts

GRAL contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for GRAL in this window.
Lobbying spend

GRAL lobbying filings, year to date.

Registered lobbying filings matched to Grail Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for GRAL in this window.
Loading news for GRAL
Analyst ratings
Sovereign unlock shows live analyst consensus for GRAL.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.